{"link": "http://hdl.handle.net/10138/154752", "subject": "farmasi', 'farmasi", "wordcount": 18327, "major": "Cell-based bioluminescent high-throughput screening methods in antibacterial drug discovery", "abstract": "Due to the emergence of multidrug resistant bacteria, bacterial infections are still a major healthcare problem. Many factors have led to a discovery void of new antibacterial agents, rendering the current antibiotic pipeline inadequate for future medical needs. For example, the outcomes from pure biochemical high-throughput screening (HTS) assays have, in many cases, not led to successful clinical compounds. Therefore cell-based assays might be a better choice for primary screening. However, the antibacterial cell-based assays in the current use often require long incubation times and they are not always amenable for miniaturization and automation for HTS. \\n\\nIn this work, two screening assays based on recombinant bioluminescent E. coli strains were optimized and implemented in the screening of chemical libraries and natural products in antibacterial drug discovery. One of the recombinant bacterial strains was a strain which is sensitive towards transcriptional and translational inhibitors. The assay based on this strain was successfully miniaturized into 384-format using automatized liquid handling and was validated with a proof-of-concept library containing known drugs. This provided a means to perform a larger scale high throughput screen of a compound library. Based on the HTS hit structures, a ligand-based in silico screening of a virtual chemical library was employed for hit enrichment. The most active hits and the in silico selected compounds were further investigated in more detail. Natural products have been an important source in drug discovery, especially in the discovery of antibiotics in the current use. However, matrix effects such as colour or turbidity of natural product extracts can potentially cause interference in conventional absorbance based microbial growth inhibition assays. Also, conventional antibacterial assays are usually not sensitive enough for detecting very small concentrations in fractionated natural product extracts. The feasibility of bioreporter -based assays in antimicrobial screening of natural products was demonstrated by screening an in-house natural product library. One of the assays was also implemented for investigating the antibacterial properties of an extract from a fungal culture filtrate, which demonstrated the sensitivity of the assay for identification of active components from fractionated samples. \\n\\nIn conclusion, sensitive and reproducible bioassays amenable for further miniaturization and automation were developed for antibacterial drug discovery. Compared to conventional antimicrobial testing, the bioreporter-based methods offer important improvements such as simultaneous data acquirement on antimicrobial activity, first indication of mode of action and significant reduction of assay time to 2-4 h compared to 24 h in standard susceptibility assays. The developed bioluminescent assays led to the improvement of compound throughput in antimicrobial screening: from hundreds of samples (natural product extracts and fractions) in manually performed assays in 96-well plates, to thousands of test compounds (synthetic compound libraries) in 384-well format using automated liquid handling.', 'P\u00e5 grund av uppkomsten av multiresistenta bakterier \u00e4r bakterieinfektioner fortfarande ett stort h\u00e4lsoproblem. M\u00e5nga faktorer har lett till att den nuvarande uppt\u00e4ckten av nya antibakteriella medel \u00e4r otillr\u00e4cklig f\u00f6r framtida medicinska behov. Till exempel, har s\u00e5llingsmetoder baserade p\u00e5 enbart k\u00e4nda antibakteriella m\u00e5lproteiner inte lett till uppt\u00e4ckten av tillr\u00e4ckligt m\u00e5nga nya antibakteriella f\u00f6reningar. D\u00e4rf\u00f6r kan cellbaserade metoder vara ett b\u00e4ttre val f\u00f6r prim\u00e4rs\u00e5llning av molekyler f\u00f6r uppt\u00e4ckten av nya potentiella f\u00f6reningar f\u00f6r l\u00e4kemedelsutveckling. Emellertid, kr\u00e4ver de nuvarande standardmetoderna som anv\u00e4nds i antibakteriella analyser ofta l\u00e5nga inkubationstider. Metoderna \u00e4r inte heller alltid l\u00e4mpade f\u00f6r miniatyrisering och automation f\u00f6r s\u00e5llning av stora molekylbibliotek i laboratorief\u00f6rh\u00e5llanden. \\n\\nNaturprodukter har varit en viktig k\u00e4lla i l\u00e4kemedelsutveckling, s\u00e4rskilt i uppt\u00e4ckten av antibiotika som anv\u00e4nds idag. Ibland kan f\u00e4rgen eller grumligheten av naturprodukternas extrakt orsaka st\u00f6rningar i standardmetoderna. De konventionella metoderna \u00e4r ibland inte tillr\u00e4ckligt k\u00e4nsliga f\u00f6r att uppt\u00e4cka mycket sm\u00e5 koncentrationer av aktiva \u00e4mnen som finns t.ex. i fraktionerade naturprodukter. \\n\\nI denna avhandling utvecklades k\u00e4nsliga och reproducerbara s\u00e5llingsmetoder som ytterligare miniatyriserades, automatiserades och implementerades i s\u00e5llning av kemiska bibliotek. D\u00e4rtill unders\u00f6ktes \u00e4ven anv\u00e4ndingen av dessa s\u00e5 kallade bioreportermetoder i antibakteriell s\u00e5llning av naturprodukter. L\u00e4mpligheten p\u00e5visades genom att tests\u00e5lla ett bibliotek av v\u00e4xtextrakt samt en unders\u00f6kning av de antibakteriella egenskaperna hos ett extrakt av en svampkultur. \\n\\nS\u00e5llningsmetoderna var baserade p\u00e5 tv\u00e5 olika genmodifierade bioluminescenta (sj\u00e4lvlysande) E. coli bakteriestammar. En av de bakteriestammarna som anv\u00e4ndes var specifik f\u00f6r uppt\u00e4ckten av proteinsyntes inhiberare (transkription och translation). Metoden miniatyriserades till 384-microtiterplattor och med hj\u00e4lp av automatiserad v\u00e4tskehantering bekr\u00e4ftades metodens tillf\u00f6rlitlighet genom en tests\u00e5llning av ett bibliotek inneh\u00e5llande k\u00e4nda l\u00e4kemedel. D\u00e4refter anv\u00e4ndes den automatiserade metoden till att utf\u00f6ra en s\u00e5llning av ett molekylbibliotek i en st\u00f6rre skala. Baserat p\u00e5 de strukturer som identifierades som mest aktiva, gjordes \u00e4ven en datorbaserad s\u00e5llning av ett virtuellt kemiskt bibliotek f\u00f6r att hitta liknande strukturer. De utvalda f\u00f6reningarna unders\u00f6ktes vidare i n\u00e4rmare detalj. \\n\\nMed hj\u00e4lp av dessa metoder kan f\u00f6rb\u00e4ttringar i den antibakteriella s\u00e5llningen \u00e5stadkommas, s\u00e5som samtidig detektion av antimikrobiell aktivitet, f\u00f6rsta indikation p\u00e5 verkningss\u00e4tt och betydande minskning av analystiden till 2-4 timmar j\u00e4mf\u00f6rt med 24 timmar i standardmetoder. Miniatyrisering och optimeringen av metoderna ledde till att analysm\u00e4ngden kunde ut\u00f6kas fr\u00e5n hundratals prover i manuellt utf\u00f6rda analyser till tusentals f\u00f6reningar med hj\u00e4lp av automatiserad v\u00e4tskehantering.", "faculty": "farmasia", "charcount": 106555, "commonwords": [["assay", 185], ["screening", 143], ["al", 133], ["et", 128], ["drug", 123], ["compounds", 120], ["assays", 113], ["discovery", 97], ["bacterial", 88], ["hts", 85], ["antibacterial", 84], ["natural", 76], ["also", 73], ["used", 68], ["bacteria", 66], ["based", 60], ["using", 60], ["antibiotics", 58], ["compound", 57], ["methods", 57]], "keywords": "", "unit": "farmasian tiedekunta', 'Helsingfors universitet, farmaceutiska fakulteten', 'University of Helsinki, Faculty of Pharmacy, Faculty of Pharmacy', 'Centre for Drug Research;Division of Pharmaceutical Biosciences", "status": "doctor", "thesistype": "V\u00e4it\u00f6skirja (artikkeli)', 'Doctoral dissertation (article-based)', 'Doktorsavhandling (sammanl\u00e4ggning)', 'Text", "pagecount": 69, "title": "Cell-based bioluminescent high-throughput screening methods in antibacterial drug discovery", "language": "en", "author": "Nybond, Susanna", "date": "2015-06-04", "distinctwords": 3714}